News | December 18, 2023
Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
10+ emerging markets, Japan & ANZ transition in final phase
10+ emerging markets, Japan & ANZ transition in final phase
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Eris Lifesciences enters into term loan agreement with Citi Bank
Subscribe To Our Newsletter & Stay Updated
